APGE

Apogee Therapeutics, Inc.

Healthcare · Biotechnology

135.10$ +0.0% vs. previous close Closing price · As of: Sep 3, 2026

Statements

Cash Flow

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow APGE
Line item	2022	2023	2024	2025
Operating Cash Flow	-0.32	-1.48	-3.10	-3.75
Depreciation & Amortization	–	0.00	0.00	0.02
Stock-Based Compensation	0.04	0.12	0.42	0.76
Change in Working Capital	0.19	0.12	-0.04	-0.26
Capital Expenditures	0.00	0.00	0.02	0.08
Investing Cash Flow	–	-5.41	-5.44	-2.96
Financing Cash Flow	3.32	6.23	8.97	6.53
Change in Cash	3.00	-0.66	0.43	-0.17
Free Cash Flow	-0.32	-1.48	-3.12	-3.83

Data as of: September 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.